A previous study on mice with podocyte PTP1B disruption demonstrated that PTP1B deficiency improved hyperglycemia-induced albuminuria and renal injury and reduced inflammation and fibrosis [15]. This evidence concerns the gene PTPN1 and Hyperglycemia.